Skip to main content
. Author manuscript; available in PMC: 2020 Jun 29.
Published in final edited form as: Clin Cancer Res. 2009 Mar 17;15(7):2514–2522. doi: 10.1158/1078-0432.CCR-08-1254

Fig. 6.

Fig. 6.

Comparison of trends in CD2 saturation with different administration schedules of siplizumab with statistically significant differences between changes from baseline in weekly and biweekly schedules. Weekly showed more pronounced changes (P = 0.007).

HHS Vulnerability Disclosure